Ankylosing spondylitis
Disease2 papers2 findings
- Humans2
Associations
2Peripheral artery disease
upin humans1
1 study
Peripheral artery disease
upin humans1
Ankylosing spondylitis raises the risk of peripheral artery disease in humans (IRR 1.40, 95% CI 1.23-1.59).
Humans4.1 years
Risk of peripheral artery disease following ankylosing spondylitis, 2012-2023: a nationwide cohort study in South Korea · Scandinavian journal of rheumatology · 16 Sep 2026
iPRS
upin humans1OR 1.4
1 study
iPRS
upin humans1OR 1.4
iPRS raises the risk of ankylosing spondylitis in humans (OR = 1.4, p = 1.33 × 10−17).
Humansadjusted for sex, age, EHR length, race, ethnicity, and PCsn = 265,068
Inherited predisposition to increased systemic inflammation predicts a broad class of disease phenotypes · HGG advances · 4 Sep 2026
Trial sponsors
Company1 trialPhase 3458 people
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Company1 trialPhase 3240 people
Charite University, Berlin, Germany
1 trialPhase 4156 people
1 trialPhase 4150 people
1 trialPhase 4100 people
1 trialPhase 49 people
1 trialPhase 2300 people
National Institute of Blood and Marrow Transplant (NIBMT), Pakistan
1 trialPhase 1/2200 people